Curis (CRIS) Operating Margin Growth (5y) (2015 - 2025)
Curis (CRIS) Operating Margin Growth (5y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Curis |
9.17 Mn |
-5.83 Mn |
- |
| Date | Value |
|---|
| Dec 31, 2025 |
193,150.00 |
| Sep 30, 2025 |
-4,620.00 |
| Jun 30, 2025 |
-7,006.00 |
| Mar 31, 2025 |
-11,366.00 |
| Dec 31, 2024 |
-4,576.00 |
| Sep 30, 2024 |
-17,415.00 |
| Jun 30, 2024 |
-19,817.00 |
| Mar 31, 2024 |
-28,320.00 |
| Dec 31, 2023 |
-26,562.00 |
| Sep 30, 2023 |
-21,117.00 |
| Jun 30, 2023 |
-21,915.00 |
| Mar 31, 2023 |
-10,472.00 |
| Dec 31, 2022 |
-13,552.00 |
| Sep 30, 2022 |
14,587.00 |
| Jun 30, 2022 |
667.00 |
| Mar 31, 2022 |
-2,930.00 |
| Dec 31, 2021 |
5,481.00 |
| Sep 30, 2021 |
124,918.00 |
| Jun 30, 2021 |
16,984.00 |
| Mar 31, 2021 |
10,824.00 |
